Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients
Mittendorf, E. A., Clifton, G. T., Holmes, J. P., Schneble, E., van Echo, D., Ponniah, S., Peoples, G. E.Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu211
Date:
September, 2014
File:
PDF, 277 KB
english, 2014